Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoveragePerspectivePublication Exclusive

Docetaxel extended OS for patients with relapsed esophageal, stomach cancers

HemOnc Today, March 10, 2013
Second-line treatment with docetaxel significantly improved OS among patients with advanced esophago-gastric cancer, according to results of a phase…
Meeting News CoveragePerspectivePublication Exclusive

Oral agent improved OS in Japanese patients with pancreatic cancer

HemOnc Today, February 25, 2013
Adjuvant treatment with the chemotherapy drug S-1 increased OS among Japanese patients with pancreatic cancer, according to results of a phase 3…
Meeting News CoveragePerspectivePublication Exclusive

Surgery after imatinib improved survival for patients with metastatic, recurrent GIST

HemOnc Today, February 25, 2013
Patients with metastatic or recurrent gastrointestinal stromal tumors who underwent surgery following imatinib therapy demonstrated significantly…
Meeting News Coverage

Extra-intestinal location for primary non-metastatic GIST associated with increased risk for death

HemOnc Today, February 10, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Compared with gastrointestinal stromal tumors located within the gastrointestinal tract…
Meeting News CoveragePerspective

IP cisplatin, early start of chemotherapy associated with improved efficacy of iceMFP chemotherapy

HemOnc Today, February 10, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Phase 3 results from the AMC 0101 study showed patients treated with iceMFP chemotherapy…
Meeting News Coverage

SPACE: Addition of sorafenib delayed progression in intermediate HCC

February 7, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Sorafenib improved time to progression without increasing toxicity when added to…
Meeting News CoveragePerspective

Cetuximab, brivanib failed to extend OS in metastatic colorectal carcinoma

February 6, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Despite improvements in PFS and objective response, the combination of cetuximab and…
Meeting News Coverage

Monoclonal antibody detected early-stage pancreatic cancer marker

January 31, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — A test using a monoclonal antibody to detect PAM4 protein and CA19-9 markers was able to…
Meeting News Coverage

Study identified predictive factors for neuroendocrine tumor progression

January 30, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Researchers identified that certain factors were associated with a greater probability of …
Meeting News Coverage

Biomarkers detected patients at risk for esophageal cancer

January 27, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Researchers identified biomarkers that could improve early detection of esophageal cancer …